STIMVIA

Stimvia is a medical device company based in the Czech Republic, focused on developing innovative, non-invasive neuromodulation technologies for treating chronic diseases. Their flagship product, URIS®, is a novel system designed to safely stimulate deep brain structures without the need for surgery or drugs. This technology aims to restore balance in the central nervous system and alleviate symptoms associated with conditions like overactive bladder and Parkinson’s disease. URIS® utilizes electrical impulses to stimulate specific nerves, providing an alternative to traditional invasive treatments. The system includes a mobile application that collects patient data to optimize stimulation parameters, enhancing treatment effectiveness. Stimvia is actively conducting clinical trials, including a successful Phase II study for Parkinson’s disease tremors, demonstrating safety and symptom relief. The company is also expanding its market presence beyond Europe, targeting regions such as Saudi Arabia, Kazakhstan, and Southeast Asia, while seeking strategic investments to support commercialization and regulatory approvals.

• Employees 11